Cladribine Combined with Idarubicin and Ara-C (CLIA) As a Frontline and Salvage Treatment for Young Patients (≤65 yrs) with Acute Myeloid Leukemia

被引：10
|
作者：
Jain, Preetesh [1 ]
Kantarjian, Hagop M. [1 ]
Ravandi, Farhad [1 ]
Jabbour, Elias [1 ]
Daver, Naval [1 ]
Pemmaraju, Naveen [1 ]
DiNardo, Courtney D. [1 ]
Alvarado, Yesid [1 ]
Jain, Nitin [1 ]
Borthakur, Gautam [1 ]
Verstovsek, Srdan [1 ]
Ferrajoli, Alessandra [1 ]
Ohanian, Maro [1 ]
Konopleva, Marina [1 ]
Naqvi, Kiran [1 ]
Fitch, Tina [1 ]
Garcia-Manero, Guillermo [1 ]
Cortes, Jorge E. [1 ]
Estrov, Zeev [1 ]
Kadia, Tapan M. [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA
来源：
BLOOD | 2016年 / 128卷 / 22期
关键词：
D O I：
10.1182/blood.V128.22.1639.1639
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1639
引用
收藏
页数：6
相关论文
共 50 条
  • [31] PHASE I-II STUDY OF IDARUBICIN AND CYTARABINE (ARA-C) IN ACUTE-LEUKEMIA
    BERMAN, E
    ARLIN, Z
    DAGHESTANI, A
    GEE, T
    KEMPIN, S
    MERTELSMANN, R
    ANDREEF, M
    HANCOCK, C
    BARATZ, R
    WILLIAMS, L
    CLARKSON, B
    YOUNG, C
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1984, 25 (MAR): : 187 - 187
  • [32] Randomized evaluation of quizartinib and low-dose ara-C vs low-dose ara-C in older acute myeloid leukemia patients
    Dennis, Mike
    Thomas, Ian F.
    Ariti, Cono
    Upton, Laura
    Burnett, Alan K.
    Gilkes, Amanda
    Radia, Rohini
    Hemmaway, Claire
    Mehta, Priyanka
    Knapper, Steven
    Clark, Richard E.
    Copland, Mhairi
    Russell, Nigel
    Hills, Robert K.
    BLOOD ADVANCES, 2021, 5 (24) : 5621 - 5625
  • [33] LOW-DOSE ARA-C(LODAC) IN ACUTE MYELOID-LEUKEMIA
    AMADORI, S
    PETTI, MC
    AVVISATI, G
    SIKOGLOU, N
    MANDELLI, F
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1984, 25 (MAR): : 185 - 185
  • [34] ARA-C AND AMSA IN THE THERAPY OF RELAPSED AND REFRACTORY ACUTE MYELOID-LEUKEMIA
    JAGER, U
    WIENER KLINISCHE WOCHENSCHRIFT, 1986, 98 (17) : 589 - 589
  • [35] Autophagy induction of Acute Myeloid Leukemia (AML) cells after treatment with low dose-cytarabine (Ara-C) and enhanced cytocidal effect on AML cells by combined treatment with ara-c plus lenograstim
    Tang, Yongmin
    Li, Lixia
    Wang, Di
    Shen, Hongqiang
    Qian, Baiqin
    Luo, Chunfang
    Zhang, Haizhong
    BLOOD, 2007, 110 (11) : 114B - 114B
  • [36] TREATMENT OF REFRACTORY AND RECIDIVIST ACUTE MYELOID-LEUKEMIA WITH HIGH-DOSE ARA-C AND AMSACRINE
    KALHS, P
    KOS, M
    JAGER, U
    SCHWARZINGER, I
    BETTELHEIM, P
    PANZER, S
    HINTERBERGER, W
    NEUMANN, E
    LECHNER, K
    ONKOLOGIE, 1987, 10 (05): : 279 - 280
  • [37] Phase II study of cladribine, idarubicin, cytarabine (CLIA) plus gilteritinib in patients (pts) with FLT3 mutated acute myeloid leukemia (AML).
    Abuasab, Tareq
    Kantarjian, Hagop M.
    Garcia-Manero, Guillermo
    Bravo, Guillermo Montalban
    Valero, Yesid Alvarado
    Daver, Naval Guastad
    Yilmaz, Musa
    Pemmaraju, Naveen
    Chien, Kelly Sharon
    Kornblau, Steven Mitchell
    Burger, Jan Andreas
    Jain, Nitin
    Islam, Rabiul
    Dinardo, Courtney Denton
    Borthakur, Gautam
    Jabbour, Elias
    Ravandi, Farhad
    Kadia, Tapan M.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [38] In vitro-in vivo pharmacodynamic analysis of GTI-2040 combined with Ara-C in acute myeloid leukemia
    Aimiuwu, Josephine
    Chen, Ping
    Xie, Zhiliang
    Liu, Zhongfa
    Sarathi, Vijay
    Liu, Shujun
    Klisovic, Rebecca
    Marcucci, Guido
    Chan, Kenneth
    CANCER RESEARCH, 2009, 69
  • [39] Minimal residual disease as biomarker for optimal biologic dosing of ARA-C in patients with acute myeloid leukemia
    Maurillo, Luca
    Buccisano, Francesco
    Piciocchi, Alfonso
    Del Principe, Maria Ilaria
    Sarlo, Chiara
    Di Veroli, Ambra
    Panetta, Paola
    Irno-Consalvo, Maria
    Nasso, Daniela
    Ditto, Concetta
    Refrigeri, Marco
    De Angelis, Gottardo
    Cerretti, Raffaella
    Arcese, William
    Sconocchia, Giuseppe
    Lo-Coco, Francesco
    Amadori, Sergio
    Venditti, Adriano
    AMERICAN JOURNAL OF HEMATOLOGY, 2015, 90 (02) : 125 - 131
  • [40] A Randomised Assessment of Vosaroxin Monotherapy and Vosaroxin Combined with Low Dose Ara-C Versus Low Dose Ara-C in Older Patients with Acute Myeloid Leukaemia
    Dennis, Michael
    Russell, Nigel H.
    Panoskaltsis, Nicki
    Hemmaway, Claire Jane
    Milligan, Donald
    Clark, Richard E.
    Hills, Robert K.
    Burnett, Alan K.
    BLOOD, 2014, 124 (21)
12345